Podcaster
Episoden
22 Minuten
This episode is a recording of the White Paper: Perspective on
Aducanumab’s Nov. 6 Advisory Committee, read by Shanti Skiffington.
12 Minuten
This week Shanti and Eliot talk to Dr. Scott Napper, Professor of
Biochemistry, Microbiology & Immunology at the University of
Saskatchewan, about the future of an Alzheimer’s Vaccine.
09.10.2020
9 Minuten
On today's episode, Shanti and Eliot talk to Dr. Neil Cashman about
a vaccine for Alzheimer’s disease and how that fits into the
detection, treatment, and prevention of the disease.
13 Minuten
Shanti and Eliot talk to Dr. Josè Luis Molinuevo of the
BarcelonaBeta Brain Research Center about his experience at AAIC,
and the presentation he gave on biomarkers.
25 Minuten
This week, Shanti and Eliot talk to founder and CEO of Unlearn,
Charles Fisher. They discuss how artificial intelligence can effect
Alzheimer's drug research.
Über diesen Podcast
Dr. Elliot Goldstein and Shanti Skiffington discuss the future of
medicine for Alzheimer’s and Parkinson’s diseases with the world's
leading researchers.
Kommentare (0)